Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors (Q95822087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

title

Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

author name string

Ryan Craig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Jeffry Cutrera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Shiguo Zhu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Xueqing Xia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Yong-Hwan Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Shulin Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

publication date

18 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

page(s)

901-906

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site

30 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Organ targeting in vivo using phage display peptide libraries

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

A tumor-homing peptide with a targeting specificity related to lymphatic vessels

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Solution structures and integrin binding activities of an RGD peptide with two isomers

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

https://api.crossref.org/works/10.1038%2FMT.2008.40

1 reference

7 January 2021

Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Mechanisms of Interferon-alpha induced apoptosis in malignant cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Nonviral interferon alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Concomitant alpha-interferon and chemotherapy in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Use of phage display to probe the evolution of binding specificity and affinity in integrins

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3).

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motif

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Regression of tumors by IFN-alpha electroporation gene therapy and analysis of the responsible genes by cDNA array

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Crystal structure of the extracellular segment of integrin alpha Vbeta3

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Electrostatics of nanosystems: application to microtubules and the ribosome

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.40

7 January 2021

Identifiers

DOI

10.1038/MT.2008.40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388923%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference